← Eichor
Condition: Esophageal Cancer Surgery Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Esophageal Cancer Surgery

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CR
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06509568Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)
NA · 1 location(s) · University Health Network, Toronto · NCT06668454Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
Phase 3 · 1 location(s) · Chinese Academy of Medical Sciences · NCT03731442Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepat
Phase N/A · 1 location(s) · University of Chicago · NCT01416714Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Ma
Phase 2 · 1 location(s) · John Waters · NCT07039526Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NA · 1 location(s) · Anhui Provincial Hospital · NCT06602843Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT03964753Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma
Phase 3 · 1 location(s) · Fujian Medical University Union Hospital · NCT04009265Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
NA · 1 location(s) · University of Pittsburgh · NCT06872515DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07162506Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
Phase 2/Phase 3 · 1 location(s) · The Cleveland Clinic · NCT06721520Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Phase 3 · 1 location(s) · Henan Cancer Hospital · NCT04280822Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma
Phase 1 · 1 location(s) · Affiliated Cancer Hospital of Shantou University Medical Col · NCT05984342Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Ca
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03161522Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT07043491The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
Phase N/A · 1 location(s) · yi shen · NCT07596654Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer
NA · 1 location(s) · Nurettin Şahin · NCT07482566Surgery As Needed for Oesophageal Cancer - 2
Phase N/A · 1 location(s) · Bas P. L. Wijnhoven · NCT04886635Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06272214Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT05517811Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05775419Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoper
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT07584577Neoadjuvant Treatment Modalities in Esophageal Cancer
Phase 3 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT04821843A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06190639Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06354218Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric J
Phase N/A · 1 location(s) · Semmelweis University · NCT06713993The French EsoGastricTumours Data Base
Phase N/A · 31 location(s) · University Hospital, Lille · NCT02526095Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT05327517Prehab for Lung and Esophageal Cancer
NA · 1 location(s) · Nova Scotia Health Authority · NCT06354959Liposomal Bupivacaine and Transoral Robotic Surgery
Phase N/A · 1 location(s) · Geisinger Clinic · NCT05862792
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.